arBtrage CAPITALIZING MARKETS checking… Sign in

Immunic, Inc.

IMUX Health Care Biotechnology: Pharmaceutical Preparations
$12.77
▼ -11.5% Today
as of Jun 7, 07:18 ET
Last 30 days +18.79% Apr 28 → Jun 05
$9.18 $10.78 $12.38 $13.97 $15.57 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$14.37
High
$14.37
Low
$12.60
Volume
$258,638
Avg Vol
$219,580
Mkt Cap
$204M
P/E (TTM)
Beta
52w High
$15.77
52w Low
$5.06
Div Yield
Shares Out
$14M

Overview

52-week range
$5.06
$16
72% of range
Avg surprise (last 2)
-26.1%
Avg reaction (last 2)
+5.4%
100% positive
Latest IV / EM
141%
EM ±19.6% · $13 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.08$-0.84$-0.60$-0.37$-0.13 Actual $-0.54Actual $-0.51Actual $-0.30Actual $-0.21Actual $-0.24Actual $-0.25Est $-0.25Actual $-0.20Actual $-0.13Actual $-1.08Est $-0.71 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-33M$-30M$-28M$-25M$-22M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-1.08 $-0.71 -52.1% -332.0% +8.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.13 financials
Mon Jun 30, 2025Jun 2025 $-0.20 financials
Thu May 15, 2025Mar/2025 $-0.25 $-0.25 0.0% +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-0.24 financials
Sun Jun 30, 2024Jun 2024 $-0.21 financials
Sun Mar 31, 2024Mar 2024 $-0.30 financials
Sat Sep 30, 2023Sep 2023 $-0.51 financials
Fri Jun 30, 2023Jun 2023 $-0.54 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-33M$-26M$-27M$-27M$-26M$-23M
Net income$-33M$-26M$-27M$-25M$-24M$-21M
EPS (diluted)$-1.08$-0.13$-0.20$-2.51$-0.24$-0.21

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$187M$15M$35M$55M$14M$36M$59M$80M
Inventory
Total current assets$189M$23M$39M$60M$19M$39M$63M$85M
Total assets$190M$24M$41M$61M$21M$41M$65M$86M
Long-term debt
Total liabilities$39M$31M$30M$28M$26M$22M$24M$23M
Total equity$151M$-7M$10M$34M$-5M$18M$41M$64M

Implied volatility — last 90 days

136%138%141%143%146% Jun 07 — IV 141% · EM ±19.6%

Sector peers